NCT04922307View on ClinicalTrials.gov

Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2027

Conditions
Kidney Cancer
Interventions
PROCEDURE

Blood Sparing Protocol

Acute Normovolemic Hemodilution, Cell Saver, and/or Veno-venous Bypass

PROCEDURE

Standard Blood Replacement

Allogenic blood transfusion as determined intra-operatively

Trial Locations (3)

30322

Winship Cancer Institute at Emory University, Atlanta

33612

H. Lee Moffitt Cancer Center, Tampa

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER